Back

Efficacy and metabolic impact of combination therapy vs. high-intensity statin monotherapy: an exploratory analysis of the Save SAMS Trial

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Soon Jun Hong

Korea University Anam Hospital, Seoul (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Z. Zhang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Doctor E. Bolsteina (Riga, LV)
Abstract Slides
Presentation thumbnail
Ms H. Shen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Doctor X. Liu (CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative safety and efficacy of combination lipid lowering therapy versus high-intensity statin in elderly patients with atherosclerotic cardiovascular disease
thumbnail
Congress Presentation
Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events
thumbnail
Congress Presentation
Efficacy of combination therapy with statin and ezetimibe versus high dose statin monotherapy in secondary prevention in high-risk patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources